These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 11181928)

  • 1. Complexities of measuring antagonist potency at P2X(7) receptor orthologs.
    Hibell AD; Thompson KM; Xing M; Humphrey PP; Michel AD
    J Pharmacol Exp Ther; 2001 Mar; 296(3):947-57. PubMed ID: 11181928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antagonist effects on human P2X(7) receptor-mediated cellular accumulation of YO-PRO-1.
    Michel AD; Kaur R; Chessell IP; Humphrey PP
    Br J Pharmacol; 2000 Jun; 130(3):513-20. PubMed ID: 10821778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional characterization of the P2X(4) receptor orthologues.
    Jones CA; Chessell IP; Simon J; Barnard EA; Miller KJ; Michel AD; Humphrey PP
    Br J Pharmacol; 2000 Jan; 129(2):388-94. PubMed ID: 10694247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological characterization of the P2X(7) receptor on human macrophages using the patch-clamp technique.
    Eschke D; Wüst M; Hauschildt S; Nieber K
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):168-71. PubMed ID: 11819036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P2X7 receptors at adult neural progenitor cells of the mouse subventricular zone.
    Messemer N; Kunert C; Grohmann M; Sobottka H; Nieber K; Zimmermann H; Franke H; Nörenberg W; Straub I; Schaefer M; Riedel T; Illes P; Rubini P
    Neuropharmacology; 2013 Oct; 73():122-37. PubMed ID: 23727220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of ATP-induced current through P2X7 receptor in NG108-15 cells: unique antagonist sensitivity and lack of pore formation.
    Watano T; Matsuoka I; Kimura J
    Jpn J Pharmacol; 2002 Apr; 88(4):428-35. PubMed ID: 12046986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cloning and pharmacological characterization of the guinea pig P2X7 receptor orthologue.
    Fonfria E; Clay WC; Levy DS; Goodwin JA; Roman S; Smith GD; Condreay JP; Michel AD
    Br J Pharmacol; 2008 Feb; 153(3):544-56. PubMed ID: 18037910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brilliant blue G selectively blocks ATP-gated rat P2X(7) receptors.
    Jiang LH; Mackenzie AB; North RA; Surprenant A
    Mol Pharmacol; 2000 Jul; 58(1):82-8. PubMed ID: 10860929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of regions of the P2X(7) receptor that contribute to human and rat species differences in antagonist effects.
    Michel AD; Clay WC; Ng SW; Roman S; Thompson K; Condreay JP; Hall M; Holbrook J; Livermore D; Senger S
    Br J Pharmacol; 2008 Nov; 155(5):738-51. PubMed ID: 18660826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Negative and positive allosteric modulators of the P2X(7) receptor.
    Michel AD; Chambers LJ; Walter DS
    Br J Pharmacol; 2008 Feb; 153(4):737-50. PubMed ID: 18071294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apparent species differences in the kinetic properties of P2X(7) receptors.
    Hibell AD; Kidd EJ; Chessell IP; Humphrey PP; Michel AD
    Br J Pharmacol; 2000 May; 130(1):167-73. PubMed ID: 10781013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decavanadate, a P2X receptor antagonist, and its use to study ligand interactions with P2X7 receptors.
    Michel AD; Xing M; Thompson KM; Jones CA; Humphrey PP
    Eur J Pharmacol; 2006 Mar; 534(1-3):19-29. PubMed ID: 16487507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics of antagonist actions at rat P2X2/3 heteromeric receptors.
    Spelta V; Jiang LH; Surprenant A; North RA
    Br J Pharmacol; 2002 Mar; 135(6):1524-30. PubMed ID: 11906966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ca(2+)-dependent reduction of glutamate aspartate transporter GLAST expression in astrocytes by P2X(7) receptor-mediated phosphoinositide 3-kinase signaling.
    Liu YP; Yang CS; Chen MC; Sun SH; Tzeng SF
    J Neurochem; 2010 Apr; 113(1):213-27. PubMed ID: 20070863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum constituents can affect 2'-& 3'-O-(4-benzoylbenzoyl)-ATP potency at P2X(7) receptors.
    Michel AD; Xing M; Humphrey PP
    Br J Pharmacol; 2001 Apr; 132(7):1501-8. PubMed ID: 11264244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allosteric modulation and accelerated resensitization of human P2X(3) receptors by cibacron blue.
    Alexander K; Niforatos W; Bianchi B; Burgard EC; Lynch KJ; Kowaluk EA; Jarvis MF; van Biesen T
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1135-42. PubMed ID: 10565834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological characterization of P2X7 receptors in rat peritoneal cells.
    Chen YW; Donnelly-Roberts DL; Namovic MT; Gintant GA; Cox BF; Jarvis MF; Harris RR
    Inflamm Res; 2005 Mar; 54(3):119-26. PubMed ID: 15883745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitogen-activated protein kinase and caspase signaling pathways are required for P2X7 receptor (P2X7R)-induced pore formation in human THP-1 cells.
    Donnelly-Roberts DL; Namovic MT; Faltynek CR; Jarvis MF
    J Pharmacol Exp Ther; 2004 Mar; 308(3):1053-61. PubMed ID: 14634045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P2X purinergic receptor antagonist accelerates skin barrier repair and prevents epidermal hyperplasia induced by skin barrier disruption.
    Denda M; Inoue K; Fuziwara S; Denda S
    J Invest Dermatol; 2002 Nov; 119(5):1034-40. PubMed ID: 12445189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional expression of ionotropic purinergic receptors on mouse taste bud cells.
    Hayato R; Ohtubo Y; Yoshii K
    J Physiol; 2007 Oct; 584(Pt 2):473-88. PubMed ID: 17702819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.